Skip to content

Hansoh Pharmaceutical Group Ltd Sustainability Reports

Hansoh Pharmaceutical Group Company Limited is an innovation-driven biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of innovative medicines. The company focuses primarily on therapeutic areas such as oncology, anti-infectives, central nervous system diseases, metabolism, and immunology.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG00P78Y7P9

12 reports from 2019 to 2025